MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-08-2025
Surmodics ROA Ratio 2011-2026 | SRDX
Annual ROA Ratio Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.46 | -0.83 | -17.22 | 2.18 | 0.67 | 4.75 | -2.72 | 2.87 | 7.51 | 12.1 | 11.47 | 14.88 | 9.93 | -7.86 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.88 | -17.22 | 2.23 |
Quarterly ROA Ratio Surmodics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.81 | -13.94 | -10.61 | -4.56 | -0.67 | 7.48 | 2.69 | -5.39 | -5.39 | -11.49 | -9.05 | -5.95 | 0.42 | -1.44 | 4.94 | 6.29 | 0.39 | 3.7 | -0.62 | -0.36 | 3.61 | 3.07 | 3.33 | 4.1 | 0.81 | -1.74 | -1.03 | -3.06 | -1.7 | 0.46 | -1.48 | 1.47 | 3.12 | 5.55 | 8.42 | 8.99 | 8.43 | 9.45 | 10.26 | 12.04 | 12.9 | 12.36 | 13.26 | 12.93 | 14.31 | 13.95 | 14.07 | 14.19 | 14.11 | 14.04 | 14.6 | 13.45 | -1.99 | -2.54 | -4.93 | -11.91 | 2.45 | 1.73 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.6 | -13.94 | 2.84 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M |  USA |
 |
Agilent Technologies
A
|
11.3 | $ 116.92 | 2.68 % | $ 35.5 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 25.62 | 3.18 % | $ 712 M | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Danaher Corporation
DHR
|
4.33 | $ 195.29 | 2.24 % | $ 139 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 16.25 | 2.14 % | $ 491 M | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 18.15 | 2.72 % | $ 967 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
-20.67 | $ 94.73 | 1.53 % | $ 11.9 B | USA |
 |
DexCom
DXCM
|
13.19 | $ 65.41 | 3.64 % | $ 25.5 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 16.5 | 2.52 % | $ 178 M |  China |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 108.69 | 1.43 % | $ 8.97 B |  Irlanda |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 127.4 | 0.76 % | $ 20.3 B | USA |
 |
IQVIA Holdings
IQV
|
4.54 | $ 174.05 | 2.06 % | $ 29.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 274.58 | 2.01 % | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 79.47 | 1.78 % | $ 5.36 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 176.29 | 3.94 % | $ 8.74 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K |  Israel |
 |
Medpace Holdings
MEDP
|
22.84 | $ 522.84 | 2.82 % | $ 15.1 B | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 318.82 | 3.84 % | $ 27.2 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 4.87 | 2.64 % | $ 451 M | USA |
|
Biodesix
BDSX
|
-44.15 | $ 14.75 | 1.48 % | $ 1.91 B | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.36 | 3.72 % | $ 1.07 B | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 10.53 | 5.51 % | $ 2.28 B | USA |
 |
OpGen
OPGN
|
121.6 | - | -16.95 % | $ 1.54 M | USA |
 |
Natera
NTRA
|
-39.28 | $ 212.64 | 1.61 % | $ 20.9 B | USA |
 |
PerkinElmer
PKI
|
1.98 | - | -0.91 % | $ 14.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
-69.68 | $ 1.5 | 3.82 % | $ 450 M | USA |
 |
Quotient Limited
QTNT
|
-50.51 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Precipio
PRPO
|
-1.7 | $ 28.4 | -0.37 % | $ 45.6 M | USA |
 |
Personalis
PSNL
|
-30.08 | $ 6.5 | 5.35 % | $ 385 M | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
-67.95 | $ 2.68 | -0.56 % | $ 87 K | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.14 | -0.93 % | $ 4.92 M | USA |
 |
BioNano Genomics
BNGO
|
-35.87 | $ 1.17 | 0.17 % | $ 6.37 M | USA |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 2.0 | 0.25 % | $ 8.85 M | USA |